Rothschild Investment »

Diamedica Therapeutics shares owned by Rothschild Investment

Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by Rothschild Investment from 13F filings

Historical chart of Rothschild Investment investment in Diamedica Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Diamedica Therapeutics held by Rothschild Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Diamedica Therapeutics by Rothschild Investment

Quarter filed Position value Share count Share price at filing
2026-03-31 $20 3 6.67

More positions owned by Rothschild Investment

Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Jpmorgan Chase & Co Stock (JPM)
Invesco Rafi Us 1000 Etf Etf (PRF)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Amazon Stock (AMZN)
Microsoft Corp Stock (MSFT)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Exxon Mobil Corp Stock (XOM)
Johnson & Johnson Stock (JNJ)
Capital Group Dividend Growers Etf Etf (CGDG)
Blackstone Stock (BX)
Abbvie Stock (ABBV)
Chevron Corporation Stock (CVX)

View all positions for Rothschild Investment

Top funds holding Diamedica Therapeutics

Omega Advisors
BlackRock
Millennium Management
Paragon Associates & Paragon Associates Ii Joint Venture
Geode Capital Management
Vanguard Group
State Street Corporation
First Manhattan
Bleichroeder
Vanguard Capital Management
Northern Trust
Advisor Group Holdings
LPL Financial
Vanguard Portfolio Management
Vanguard Fiduciary Trust

View all funds holding Diamedica Therapeutics